{
  "id": 1768147203702,
  "seqId": 18,
  "title": "Peripheral Ulcerative Keratitis (PUK) & Peripheral Corneal Disease",
  "summary": "An exhaustive clinical guide to aggressive, sight-threatening PUK, its systemic associations, Mooren’s ulcer, and other essential peripheral corneal pathologies from marginal keratitis to Terrien’s degeneration.",
  "date": "2026-01-11T16:00:03.702Z",
  "data": {
    "title": "Peripheral Ulcerative Keratitis (PUK) & Peripheral Corneal Disease",
    "summary": "An exhaustive clinical guide to aggressive, sight-threatening PUK, its systemic associations, Mooren’s ulcer, and other essential peripheral corneal pathologies from marginal keratitis to Terrien’s degeneration.",
    "summary_illustration": "<svg viewBox=\"0 0 100 100\" xmlns=\"http://www.w3.org/2000/svg\"><circle cx=\"50\" cy=\"50\" r=\"40\" stroke=\"hsl(215, 90%, 45%)\" stroke-width=\"2\" fill=\"none\"/><path d=\"M20 50 A30 30 0 0 1 80 50\" stroke=\"red\" stroke-width=\"4\" fill=\"none\" stroke-dasharray=\"5,2\"/><circle cx=\"50\" cy=\"50\" r=\"15\" fill=\"hsl(215, 90%, 45%)\" fill-opacity=\"0.2\"/><text x=\"50\" y=\"95\" font-size=\"5\" text-anchor=\"middle\" font-family=\"sans-serif\">PERIPHERAL MELT</text></svg>",
    "sections": [
      {
        "title": "PUK: Definition & Pathogenesis",
        "icon": "biotech",
        "type": "plain_text",
        "layout": "full_width",
        "color_theme": "blue",
        "content": "Peripheral ulcerative keratitis (PUK) is an aggressive, sight-threatening form of keratitis which is sometimes associated with underlying systemic disease. The aetiology is uncertain, although the rheumatoid model suggests that immune complex deposition at the limbus causes obliterative vasculitis, with subsequent corneal inflammation and stromal melt."
      },
      {
        "title": "Causes of PUK (Box 7.8)",
        "icon": "account_tree",
        "type": "mindmap",
        "layout": "full_width",
        "color_theme": "purple",
        "content": {
          "center": "PUK Aetiology",
          "branches": [
            "Organ-specific autoimmune PUK (idiopathic)",
            "gPA (formerly Wegener’s granulomatosis)",
            "RA (Rheumatoid Arthritis)",
            "SLE (Systemic Lupus Erythematosus)",
            "Sjögren’s syndrome",
            "Relapsing polychondritis",
            "Polyarteritis nodosa (PAN)",
            "Sarcoid",
            "Mycobacteria spp.",
            "Microscopic polyangiitis",
            "Churg–Strauss syndrome",
            "Type 1 diabetes"
          ]
        }
      },
      {
        "title": "Clinical Features of PUK",
        "icon": "visibility",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "blue",
        "content": [
          "Variable pain and redness (may be none); dVA.",
          "Uni-/bilateral peripheral corneal ulceration with epithelial defect and stromal thinning.",
          "Associated inflammation at the limbus (elevated, injected).",
          "Either sectoral or diffuse scleritis.",
          "NB: Do not underestimate associated dry eye (may be severe and filamentary keratitis)."
        ]
      },
      {
        "title": "Systemic Features",
        "icon": "accessibility_new",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "green",
        "content": [
          "Degenerative joints (RA)",
          "Saddle nose/deafness (gPA)",
          "Skin changes (psoriasis, scleroderma, SLE)",
          "Degenerative pinna cartilage (relapsing polychondritis)"
        ]
      },
      {
        "title": "Corneal Complications of RA (Table 7.13)",
        "icon": "grid_on",
        "type": "table",
        "layout": "full_width",
        "color_theme": "blue",
        "content": {
          "headers": [
            "Condition",
            "Description"
          ],
          "rows": [
            [
              "Marginal furrow",
              "Peripheral thinning without inflammation or loss of epithelium; ‘CL cornea’; does not perforate"
            ],
            [
              "PUK",
              "Peripheral inflammation, epithelial loss, infiltrate, and stromal loss; may perforate"
            ],
            [
              "Acute stromal keratitis",
              "Acute-onset inflammation with stromal infiltrates, but epithelium often preserved"
            ],
            [
              "Sclerosing keratitis",
              "Gradual juxtalimbal opacification of corneal stroma bordering an area of scleritis"
            ],
            [
              "Keratolysis",
              "Stromal thinning (‘corneal melt’) ± associated inflammation"
            ]
          ]
        }
      },
      {
        "title": "Comprehensive Investigations",
        "icon": "microscope",
        "type": "key_point",
        "layout": "full_width",
        "color_theme": "purple",
        "content": [
          "As directed by systemic review: Consider BP; FBC, ESR, CRP, U+E, LFT, glu, HbA1c.",
          "Vasculitis screen: Rheumatoid factor (RF), anti-cyclic citrullinated peptide (CCP), anti-nuclear antibody (ANA), anti-neutrophil cytoplasmic antibody (ANCA), dsDNA, serum angiotensin-converting enzyme (ACE).",
          "Serology & Urinalysis: Cryoglobulins, hepatitis C serology, urinalysis, CxR."
        ]
      },
      {
        "title": "PUK Treatment Strategy",
        "icon": "medical_services",
        "type": "process",
        "layout": "full_width",
        "color_theme": "green",
        "content": [
          "1. Emergency referral to corneal or inflammatory eye disease specialist; involve physician/rheumatologist.",
          "2. Exclude infection: microscopy, culture, and sensitivity and PCR (16S, 18S, DNA viruses, mycobacteria spp,, syphilis if indicated).",
          "3. Ensure adequate tear film: topical lubricants (carmellose or hyaluronate); consider punctal plugs/cautery after blepharitis treated; serum eye drops.",
          "4. Systemic immunosuppression: Corticosteroids (pulsed methylprednisolone or high-dose oral prednisolone), methotrexate, ciclosporin, mycophenolate, azathioprine, or continuous oral cyclophosphamide.",
          "5. Severe disease: Pulsed oral or IV cyclophosphamide with methylprednisolone (6–9 pulses), then steroid-sparing agent and reducing systemic oral steroids.",
          "6. Elderly Support (>60y): Bone density scans; calcium/vitamin D supplements, alendronic acid, gastric protection.",
          "7. Resistant cases: (Failed 2 immunosuppressants or unable to reduce steroid <10mg/d) Consider anti-TNF (adalimumab) or anti-CD20 (rituximab) post-funding/NICE guidance for ANCA+ vasculitis."
        ]
      },
      {
        "title": "Supportive & Surgical PUK Interventions",
        "icon": "healing",
        "type": "key_point",
        "layout": "full_width",
        "color_theme": "yellow",
        "content": [
          "Promote stromal healing: Doxycycline (inhibits proteases) and oral Vitamin C (inhibits free radicals).",
          "Topical immunosuppression: Steroids (caution: may accelerate keratolysis if thinning is significant).",
          "Prevent 2° infection: Topical antibiotics (e.g. chloramphenicol preservative-free 0.5% 4×/d).",
          "Pain/AC activity: Cycloplegic.",
          "Globe protection: Glasses (day), shield (night), botulinum toxin ptosis, or tarsorrhaphy.",
          "Pending/actual perforation: Therapeutic CL + cyanoacrylate glue.",
          "Surgical options: Conjunctival recession, AMg, tectonic freehand lamellar keratoplasty, and occasionally conjunctival flaps."
        ]
      },
      {
        "title": "Mooren’s Ulcer",
        "icon": "warning",
        "type": "plain_text",
        "layout": "full_width",
        "color_theme": "red",
        "content": "Rare autoimmune form of PUK. Rarely associated with hepatitis C. Two forms: 1. Limited form: Middle-aged/elderly Caucasians, unilateral, responsive. 2. Aggressive form: Young Africans, bilateral, relentlessly progressive despite treatment."
      },
      {
        "title": "Mooren’s Ulcer: Features & Management",
        "icon": "clinical_notes",
        "type": "key_point",
        "layout": "full_width",
        "color_theme": "red",
        "content": [
          "Clinical Features: Pain, photophobia, dVA; Progressive peripheral ulceration; Leading edge undermines epithelium; Grey infiltrate at margin; Advances centrally/circumferentially; Underlying stromal melt.",
          "NB: No perilimbal clear zone and no associated scleritis (but conjunctival/episcleral inflammation).",
          "Complications: Perforation, uveitis, cataract; at end-stage, cornea is thinned and conjunctivalized.",
          "Investigations: Systemic work-up to rule out Hep C or diseases associated with PUK.",
          "Treatment: Topical steroids (dexamethasone 0.1% PF hourly); Systemic immunosuppression (Corticosteroids, cyclophosphamide, or ciclosporin A); IFN if Hep C present (liaise with hepatologist).",
          "Other Tx: Antibiotics, cycloplegia, protection, BCL ± glue, and PUK surgical options."
        ]
      },
      {
        "title": "Marginal Keratitis",
        "icon": "emergency",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "green",
        "content": [
          "Common inflammatory hypersensitivity to staphylococcal exotoxin; associated with atopy, rosacea, or chronic blepharitis.",
          "Symptoms: Pain, FB sensation, redness (sectoral/adjacent to lids), photophobia, tearing, dVA.",
          "Signs: Sterile, white, subepithelial peripheral infiltrate (2, 4, 8, 10 o’clock); May coalesce; Perilimbal clear zone preserved; epithelial ulceration and vascularization possible.",
          "Treatment: Topical steroid/antibiotic (e.g. betamethasone 0.1% 4×/d for 1wk, 2×/d for 1wk; chloramphenicol 0.5% 4×/d for 2wk); Treat blepharitis/rosacea."
        ]
      },
      {
        "title": "Rosacea-associated Keratitis",
        "icon": "face",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "yellow",
        "content": [
          "Acne rosacea: Chronic disorder; telangiectasia, sebaceous hyperplasia; Middle age; Female bias; Fair-skinned.",
          "Clinical: Telangiectasias at lids, meibomianitis; Keratitis (inferior punctate erosions to marginal infiltrates to perforation); Facial flushing worse with alcohol/spicy food.",
          "Moderately severe Tx: Topical steroids ± antibiotics (e.g. dexamethasone 0.1% ± chloramphenicol 0.5%); Use caution if thinning (keratolysis risk).",
          "Very severe Tx: Systemic immunosuppression (e.g. azathioprine or mycophenolate)."
        ]
      },
      {
        "title": "Rosacea Antibiotic Regimens",
        "icon": "medication",
        "type": "table",
        "layout": "full_width",
        "color_theme": "yellow",
        "content": {
          "headers": [
            "Drug Class",
            "Dose/Notes"
          ],
          "rows": [
            [
              "Tetracyclines",
              "Doxycycline 100mg 1×/d (3mo) OR Oxytetracycline 500mg 2×/d (12wk); Periostat® 20mg long-term."
            ],
            [
              "Macrolides",
              "Erythromycin 500mg 2×/d."
            ]
          ]
        }
      },
      {
        "title": "Rosacea Contraindications",
        "icon": "block",
        "type": "red_flag",
        "layout": "half_width",
        "color_theme": "red",
        "content": [
          "Tetracyclines: Contraindicated in children under 12.",
          "Tetracyclines: Contraindicated in pregnant or breastfeeding women.",
          "Tetracyclines: Contraindicated in hepatic or renal impairment."
        ]
      },
      {
        "title": "Phlyctenulosis & Dellen",
        "icon": "info",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "purple",
        "content": [
          "Phlyctenulosis: Solitary limbal lesions (Rare in West, common in Africa/Children); Hypersensitivity to staph/mycobacterial proteins (rarely adenovirus, fungi, Neisseria, lymphogranuloma venereum, leishmaniasis).",
          "Phlycten Signs: Inflamed nodules (conjunctival) or grey nodules with vascularization moving limbus to central (corneal).",
          "Phlycten Tx: Topical steroid (e.g. betamethasone 0.1% 4×/d).",
          "Dellen: Non-ulcerative thinning near raised limbal lesions due to drying/tear film instability; usually asymptomatic.",
          "Dellen Tx: Lubrication; removal of precipitant (CL wear/limbal mass)."
        ]
      },
      {
        "title": "Terrien’s Marginal Degeneration",
        "icon": "insights",
        "type": "key_point",
        "layout": "full_width",
        "color_theme": "blue",
        "content": [
          "Rare, bilateral asymmetrical peripheral thinning; young to middle-aged males (3:1 M:F); non-inflammatory ectasia/degeneration.",
          "Symptoms: Initially asymptomatic; painless dVA (against-the-rule astigmatism).",
          "Signs: Yellow lipid deposition; superior marginal cornea vascularization; thinning on limbal side of lipid line; steep leading edge; Intact epithelium; Perilimbal clear zone preserved.",
          "Complications: Circumferential/central opacification; Inflammation rare (younger men).",
          "Treatment: Spectacles/CL for astigmatism; Surgical (crescentic/eccentric lamellar/PK) if risk of perforation."
        ]
      }
    ]
  },
  "chapterId": "cornea"
}